Nov
27
27
Dr Kelly's team synthesized a PDC series of PDCs designed to treat pulmonary fibrosis precisely, combining the kinase inhibitor nintedanib with a mimetic peptide chain targeting the αVβ6 integrin. Their antifibrotic activity is currently being evaluated in a mouse model of pulmonary fibrosis.
-
Public Event
-
27 Nov - 27 Nov
27 Nov 10:00 AM to 27 Nov 04:00 PM -
Hosted By Alex Brown
-
0 Posts
-
0 Photos
-
0 Videos
-
0 Reviews
-
Other
-
New York
Search
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek